Scotland: A licence to clone
Eight years after the first successful cloning of a mammal, the legal framework surrounding human cloning remains largely untested. As Edinburgh's Roslin Institute applies for the UK's first licence to clone human embryos for scientific research, Seona Burnett looks at its legal position
In 1996, the Roslin Institute in Edinburgh acquired global standing – and notoriety – when it announced the creation of the first mammal cloned from adult cells, Dolly the sheep. Having been awarded the first UK licence for human embryo research in 2003, it now seems set to continue its groundbreaking ways, with the announcement that Professor Ian Wilmut, Dolly’s creator, has applied for what will be the first licence granted by the Human Fertilisation and Embryology Authority (HFEA) for creation, by cloning, of human embryos for research into motor neurone disease. This is known as therapeutic cloning.
This premium content is reserved for
Legal Week Subscribers.
A PREMIUM SUBSCRIPTION PROVIDES:
- Trusted insight, news and analysis from the UK and across the globe
- Connections to senior business lawyers within the leading law firms and legal departments
- Unique access to ALM's unrivalled, market-leading reporting in the US and Asia and cutting-edge research, including Legal Week's UK Top 50 and Global 100 rankings
- The Legal Week Daily News Alert, Editor's Highlights, and Breaking News digital newsletters and more, plus a choice of over 70 ALM newsletters
- Optimized access on all of your devices: desktop, tablet and mobile
- Complete access to the site's full archive of more than 56,000 articles
Already have an account? Sign In Now
For enterprise-wide or corporate enquiries, please contact Paul Reeves on Preeves@alm.com or call on +44 (0) 203 875 0651